Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Registry to evaluate psychiatric medications during pregnancy

Official title: National Pregnancy Registry for Psychiatric Medications

Run by Massachusetts General Hospital · NCT01246765 · Data updated 2026-11-12

This study is trying to see if using certain psychiatric medications during pregnancy is safe for both mothers and their babies.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment5000 (estimated)
SponsorMassachusetts General Hospital
Academic / other
Locations1 site (Boston, Massachusetts)
StatusRecruiting
StartedNovember 2008
Main results expectedDecember 2033
Study endsDecember 2033
Registry record updatedNovember 6, 2026
Trial IDNCT01246765 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant women aged 18-45 who are currently taking psychiatric medications.

Probably not a fit

Women who have completed their pregnancy or are planning to become pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The National Pregnancy Registry for Psychiatric Medications aims to assess the safety of various psychiatric medications, including antidepressants and atypical antipsychotics, used by pregnant women. This observational study will systematically document medication exposure during pregnancy and evaluate the associated risks of congenital malformations and neonatal outcomes. By gathering comprehensive data, the registry seeks to provide clinicians with reliable information regarding the reproductive safety of these medications, which is currently limited. This initiative represents one of the largest hospital-based efforts to monitor pregnancy outcomes related to psychiatric medication use.

Why it matters

Potential benefit: If successful, this registry could provide critical insights into the safety of psychiatric medications during pregnancy, guiding treatment decisions for expectant mothers.

How similar studies have gone: While there have been smaller studies on medication safety during pregnancy, this registry represents a novel and comprehensive approach to systematically evaluate the risks associated with psychiatric medications.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant women
* Age 18-45
* Subjects will be willing to participate over the phone
* Subjects will be able to provide informed consent

Exclusion Criteria:

* Women who have completed their pregnancy
* Women who are planning to become pregnant
* Women who are not taking any psychiatric medications and/or have no history of psychiatric illness

Where it's running

  • Massachusetts General Hospital
    Boston, Massachusetts, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.